Lilly Provides Update on A4 Study of Solanezumab for Preclinical Alzheimer's Disease
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street futures edge lower after AI selloff, telecom slide
- Brent crude hits more than five-month high on concern over Middle East escalation
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- UBS sees dip buyers stepping in to support gold at this level
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1306.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1306.69 | 52 Week High | $88.16 | |||
| Open | $1306.69 | 52 Week Low | $67.88 | |||
| Day High | $1306.69 | P/E | 302.47 | |||
| Day Low | $1306.69 | EPS | $4.32 | |||
| Volume | 10,408 | |||||
